Trial Profile
The effect of ruboxistaurin mesylate (LY333531) on small fiber function as measured by microvascular skin blood flow, C-fiber quantitations in skin and quantitative sensory testing of cold and heat
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2016
Price :
$35
*
At a glance
- Drugs Ruboxistaurin (Primary)
- Indications Diabetic neuropathies
- Focus Pharmacodynamics; Therapeutic Use
- 11 Aug 2006 Status change
- 07 Nov 2005 New trial record.